Showing 20,701 - 20,720 results of 65,167 for search '(( 50 ((a decrease) OR (we decrease)) ) OR ( a ((fold decrease) OR (mean decrease)) ))', query time: 0.84s Refine Results
  1. 20701
  2. 20702
  3. 20703
  4. 20704
  5. 20705
  6. 20706
  7. 20707
  8. 20708
  9. 20709
  10. 20710
  11. 20711
  12. 20712
  13. 20713
  14. 20714

    Effect of a spray formulation on the reproductive parameters of a susceptible population of Rhipicephalus (Boophilus) microplus by Breno Cayeiro Cruz (5311052)

    Published 2018
    “…The engorged female weight (days 1 to 7), weight of egg masses (days 5 to 10) and larval hatching percentage (days 5 to 19) were decreased (P ≤ 0.05). It is possible that a formulation can lead to deleterious effects on R. …”
  15. 20715
  16. 20716

    Table 1_Fibromyalgia diagnosis from a multi-omics approach: a gut feeling.pdf by Elena Durán-González (17438448)

    Published 2025
    “…After the raw data analysis, proteins with statistically significant differential abundance and a fold change over 1.2 (20% increase in fibromyalgia compared with control samples) or under 0.8 (20% decrease in fibromyalgia compared with control samples) in fibromyalgia were selected. …”
  17. 20717

    Meibomian gland histopathological alterations and tissue fibrosis in the <i>Sod1</i><sup>−/−</sup> and wild type mice. by Osama M. A. Ibrahim (600549)

    Published 2014
    “…<p>A, Representative images for meibomian glands from the 10 and 50 week Cu, Zn-Superoxide Dismutase-1 knockout (<i>Sod1</i><sup>−/−</sup>) and wild type (WT) mice show normal meibomian gland acinar units morphology. …”
  18. 20718

    Design, Synthesis, and Biological Evaluation of Novel Selenium-Containing <i>Iso</i>combretastatins and Phenstatins as Antitumor Agents by Yanqing Pang (4386715)

    Published 2017
    “…Most of these selenium containing hybrids exhibited potent cytotoxicity against a panel of cancel cell lines, with IC<sub>50</sub> values in the submicromolar concentration range. …”
  19. 20719

    GSTM3 A/B Polymorphism and Risk for Head and Neck Cancer: A Meta-Analysis by Yu Xu (52257)

    Published 2014
    “…Stratification by tumor site indicated that the GSTM3 polymorphism was associated with a decreased risk of laryngeal cancer under recessive model and homozygote comparison (OR = 0.52, 95%CI: 0.30–0.89; and OR = 0.50, 95%CI: 0.29–0.87, respectively); By stratifying source of control, decreased cancer risk was observed in hospital-based population under all genetic models (OR = 0.67, 95%CI: 0.56–0.81 for the dominant model; OR = 0.66, 95%CI: 0.46–0.95 for the recessive model; OR = 0.55, 95%CI: 0.37–0.83 for the homozygote comparison model, and OR = 0.70, 95%CI: 0.58–0.84 for the heterozygote comparison model).…”
  20. 20720